$CCCC C4 Therapeutics, Inc. Insider Trading
Get free email notifications about insider trading in C4 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in C4 Therapeutics, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in C4 Therapeutics, Inc. for free.
CIK Number: 0001662579
IRS Number: 475617627
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: CCCC
Company Address: 490 ARSENAL WAY SUITE 200 WATERTOWN 02472
Phone number: (202) 421-7994
C4 Therapeutics, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 21 2021 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Sell | S | 37.19 | 755 | 28,078 | 14,843 | 15.6 K to 14.8 K (-4.84 %) |
Jun 21 2021 | CCCC | C4 Therapeutics, I ... | White Lauren | Chief Financial Off ... | Option Exercise | A | 38.49 | 136,000 | 5,234,640 | 136,000 | |
Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | M | 4.98 | 444 | 2,211 | 4,002 | |
Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Option Exercise | M | 2.11 | 267 | 563 | 2,940 | |
Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | M | 4.98 | 444 | 2,211 | 85,146 | 84.7 K to 85.1 K (+0.52 %) |
Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Buy | M | 2.11 | 267 | 563 | 84,702 | 84.4 K to 84.7 K (+0.32 %) |
Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Gift | G | 0.00 | 2,278 | 0 | 47,316 | 45 K to 47.3 K (+5.06 %) |
Apr 14 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Gift | G | 0.00 | 2,278 | 0 | 84,435 | 82.2 K to 84.4 K (+2.77 %) |
Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Anderson Kenneth Carl | Director | Grant | A | 37.51 | 233 | 8,740 | 82,157 | 81.9 K to 82.2 K (+0.28 %) |
Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Crystal Adam | Chief Medical Offic ... | Option Exercise | M | 6.50 | 15,000 | 97,500 | 157,292 | |
Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Crystal Adam | Chief Medical Offic ... | Sell | S | 38.00 | 10,879 | 413,407 | 0 | 10.9 K to 0 (-100.00 %) |
Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Crystal Adam | Chief Medical Offic ... | Sell | S | 37.16 | 4,121 | 153,129 | 10,879 | 15 K to 10.9 K (-27.47 %) |
Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Crystal Adam | Chief Medical Offic ... | Buy | M | 6.50 | 15,000 | 97,500 | 15,000 | 0 to 15 K |
Apr 06 2021 | CCCC | C4 Therapeutics, I ... | Salter Malcolm | Director | Grant | A | 37.51 | 359 | 13,466 | 16,353 | 16 K to 16.4 K (+2.24 %) |
Apr 06 2021 | CCCC | C4 Therapeutics, I ... | COHEN ALAIN J | Director | Grant | A | 37.51 | 266 | 9,978 | 266 | 0 to 266 |